Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Xetra  >  MorphoSys AG    MOR   DE0006632003

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Xetra
08/25/2015 08/26/2015 08/27/2015 08/28/2015 08/31/2015 Date
62.65(c) 61.7(c) 63.54(c) 62.97(c) 63.03(c) Last
113 182 102 601 115 569 77 162 58 895 Volume
+3.52% -1.52% +2.98% -0.90% +0.10% Change
More quotes
Financials (€)
Sales 2015 104 M
EBIT 2015 13,0 M
Net income 2015 6,51 M
Finance 2015 237 M
Yield 2015 -
Sales 2016 60,8 M
EBIT 2016 -4,78 M
Net income 2016 -9,94 M
Finance 2016 234 M
Yield 2016 -
PER 2015 143,44
PER 2016
EV / Sales 2015 13,7x
EV / Sales 2016 23,6x
Capitalization 1 667 M
More Financials
Company
MorphoSys AG engages in the development of antibodies for therapeutic, diagnostics, and research applications.It operates through the following segments: Partnered Discovery, Proprietary Development, and AbD Serotec.The Partnered Discovery segment involves technologies for the generation of human... 
Sector
Biotechnology & Medical Research
Calendar
09/09 | 02:20pmPresentation
More about the company
Surperformance© ratings of MorphoSys AG
Trading Rating : Investor Rating :
More Ratings
Latest news on MORPHOSYS AG
08/26 MORPHOSYS : Enters into Agreement with Immatics Biotech
08/26 MORPHOSYS : and Immatics Biotechnologies Enter Strategic Alliance in Immuno-onco..
08/26 MORPHOSYS : and Immatics Biotechnologies Enter Strategic Alliance in Immuno-onco..
08/25 MORPHOSYS : and Immatics Biotechnologies Enter Strategic Alliance in Immuno-onco..
08/05 MORPHOSYS : and G7 Therapeutics Sign Alliance to Develop Innovative Antibody The..
08/05 MORPHOSYS : and G7 Therapeutics Sign Alliance to Develop Innovative Antibody The..
08/04 MORPHOSYS : and G7 Therapeutics Sign Alliance to Develop Innovative Antibody The..
07/31 MORPHOSYS : Partner Heptares Initiates Proprietary Therapeutic Antibody Program ..
More news
Sector news : Biotechnology & Medical Research - NEC
11:06a GENMAB A/S : Total Number of Voting Rights and Total Share Capital
07:50a MEDICINES : shares surge on upbeat cholesterol drug study
07:01a INTREXON : Soligenix Announces Completion of Patient Enrollment into its Phase 2..
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
07/27 MorphoSys' (MPSYF) CEO Simon Moroney on Q2 2015 Results - Earnings Call Trans..
07/21 MORPHOSYS : Dozens Of Partnerships And Self-Funded Growth
05/05 MorphoSys's (MPSYF) CEO Seth Fischer on Q1 2015 Results - Earnings Call Trans..
04/17 CELGENE : A Pre-Earnings Discussion Based On Recent News
02/26 MorphoSys' (MPSYF) CEO Simon Moroney on Q4 2014 Results - Earnings Call Trans..


Comments 
Advertisement
Chart MORPHOSYS AG
Duration : Period :
MorphoSys AG Technical Analysis Chart | MOR | DE0006632003 | 4-Traders
Full-screen chart
Technical analysis trends MORPHOSYS AG
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions